(MedPage Today) — Low-dose buprenorphine significantly enhanced the antisuicidal effects of a single infusion of ketamine in patients with suicidal ideation and major depressive disorder (MDD), a randomized trial showed.
Among 45 patients who…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
